A lack of patient retention across DCTs demonstrates it has many disadvantages when compared to traditional clinical trials.
The contraceptive market has been dominated by IUDs and OCs for the past decade.
The antidepressant REL-1017 will still need to demonstrate efficacy in a placebo-controlled trial, following a previous Phase III trial.
Eliminating HBV and HCV by 2030 is an ambitious goal that requires coordinated efforts.
Preventative measures against HPV consist of vaccination and condom use.
Give your business an edge with our leading industry insights.
According to GlobalData, global sales for Trodelvy are expected to reach nearly $3bn by 2029, driven by expansion into new indications such as NSCLC.
Both diseases shared the same seven genetic loci, which led researchers to confirm that depression was a major risk for diabetes.
GlobalData believes that this study could be of high clinical value to cardiologists looking to find an optimal treatment of choice for patients with acute HF.
NAFLD, commonly referred to as a “silent” disease, can be difficult to diagnose early as patients rarely experience any symptoms in the earlier stages.
Despite the rising number of cases, the initial detection of fungal diseases is often inadequate, leading to misdiagnoses or delayed diagnoses that can cost lives.